Patients in the EU with Fanconi anaemia (FA) could soon have the first gene therapy option for the disorder, as the EMA starts a review of Rocket Pharma’s RP-L102 candidate. FA is an inherited ...
Charles C. W. Cooke is a senior editor at National Review and the host of The Charles C. W. Cooke Podcast. Outside of periods of global catastrophe, rates have long been considerably higher than they ...
Allianz is the worst company to deal with. I have multiple contracts with them and someone else’s name was put on all of my contracts without my knowledge. I had to go through identity fraud, police ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results